pharmaceutical-research
3 stories related to this topic, newest first.
manilatimes.netGENFIT Presents Seven Posters at EASL Congress 2026
GENFIT will present seven posters at the EASL Congress 2026 covering research on acute-on-chronic liver failure and real-world data. The company also noted upcoming meetings on ACLF definitions and governance.
benzinga.comSanofi Reports Phase 2 Results for Efdoralprin Alfa in Alpha-1 Antitrypsin Deficiency
Sanofi announced that its Phase 2 Elevaate study showed efdoralprin alfa normalized and maintained functional AAT levels in patients with alpha-1 antitrypsin deficiency. All key secondary endpoints were met and the treatment was well tolerated.
nbcnews.comDaily Pill Maintains 70% of Weight Loss vs 38-50% on Placebo One Year After Stopping GLP-1 Injections
A new study shows patients taking daily orforglipron kept more than 70 percent of prior weight loss after one year off jabs, compared with 38-50 percent for those on placebo. The Eli Lilly drug, already available in the US at around $149 per month for the lowest dose, offers a ch…